BPI France, alongside Sanofi, Boehringer Ingelheim, Takeda, Ipsen and Servier, have launched InnoBio 2, setting a target of €200-250m and aiming for a first close in September.
Richards and Dunwoodie both held the role of investment team principals prior to the promotion
Adams Street held a first close on $125m in December 2017 and had raised $225m by April 2018
DCI’s bolt-on of communications specialist Retis follows the acquisition of Lhexian last year
Exit delivers a 2x return on YFM Equity Partners' original £9m investment, made in September 2013